Advanced brain imaging techniques for understanding brain disorders
Core B: Neuroimaging Core
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA AT DAVIS · NIH-10911233
This study is looking at how certain brain disorders caused by exposure to specific chemicals affect the brain, using advanced imaging techniques like MRI and CT scans, to help improve diagnosis and treatment for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA AT DAVIS (nih funded) |
| Locations | 1 site (DAVIS, UNITED STATES) |
| Trial ID | NIH-10911233 on ClinicalTrials.gov |
What this research studies
This research focuses on providing cutting-edge neuroimaging resources to investigate brain disorders, particularly those resulting from acute organophosphate exposure. The Neuroimaging Core at UC Davis will utilize various imaging modalities, including MRI and CT scans, to analyze brain structure and function. By employing advanced imaging technologies, the project aims to identify the effects of brain disorders and develop effective therapeutic strategies. Patients may benefit from improved diagnostic and treatment options based on the findings from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who have experienced acute organophosphate exposure and exhibit neurological symptoms.
Not a fit: Patients with brain disorders unrelated to toxic exposures may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment of brain disorders caused by toxic exposures.
How similar studies have performed: Previous research has demonstrated the effectiveness of neuroimaging technologies in evaluating brain disorders, indicating a strong potential for success in this approach.
Where this research is happening
DAVIS, UNITED STATES
- UNIVERSITY OF CALIFORNIA AT DAVIS — DAVIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHAUDHARI, ABHIJIT J — UNIVERSITY OF CALIFORNIA AT DAVIS
- Study coordinator: CHAUDHARI, ABHIJIT J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.